AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HIDROSMIN
7 registrations across 5 African markets— 7 active
Markets with HIDROSMIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Venula 200 mg capsules Capsule | 🇰🇪Kenya | FAES FARMA, S.A. | active | Jul 2030 |
| Venosmil Capsule Gelatin | 🇿🇲Zambia | FAES FARMA S.A. | active | Jun 2030 |
| VENOSMIL CAPSULES (Each capsule contains Hidrosmin 200 mg) | 🇬🇭Ghana | — | active | Jun 2030 |
| VENOSMIL CAPSULES (Each capsule contains Hidrosmin 200 mg) | 🇬🇭Ghana | — | active | Jun 2030 |
| HIDROSMIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | FAES FARMA S.A | active | — |
| VENOSMIL Capsules | 🇹🇿Tanzania | Faes Farma, S.A | active | — |
| HIDROSMIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | FAES FARMA S.A | active | — |
HIDROSMIN in Africa — Regulatory Overview
HIDROSMIN is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Kenya, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.